A two-year study with the aim of preventing sternal wound infections highlights SurgiClear as a key component of the infection prevention bundle used to significantly reduce infection rates
MISSISSAUGA, ON, Nov. 21, 2022 /PRNewswire/ – Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV:COV) (OTCQX:CVALF), an advanced medical technologies company, today announced that its SurgiClear® dressing played a key part in an infection prevention bundle that significantly reduced surgical wound infections in a two-year quality improvement study recently published by Intermountain Primary Children’s Hospital, a not-for-profit children’s hospital associated with the University of Utah and part of the Intermountain Healthcare system.1 Intermountain Primary Children’s Hospital is recognized as one of the top children’s hospitals in the united states.
Describing the impact of the bundled intervention, published in The Annals of Thoracic Surgerythe authors from Intermountain Healthcare report that the annual rate of total surgical wound infections decreased from 2.83% in 2019 to 1.15% in 2021. The bundled approach used to improve perioperative infection prevention practices included implementation of SurgiClear as ice a main practice.
Jeremy HarmanPA-C, an author on the study, commented, “The trifecta of breathable barrier protection, antimicrobials, and the ability to monitor the site is what makes this a great dressing. It’s easier for us to assess the wound and is more comfortable for patients.”
The aim of the project was to reduce the rate of surgical wound infections to less than 1.5% in pediatric cardiothoracic surgery patients. Surgical wound infections are a common complication of …